Lipoprotein(a): Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
== [[Lipoprotein(a) overview|Overview]] == | ==[[Lipoprotein(a) overview|Overview]]== | ||
== [[Lipoprotein(a) historical perspective|Historical Perspective]] == | ==[[Lipoprotein(a) historical perspective|Historical Perspective]]== | ||
== [[Lipoprotein(a) classification|Classification]] == | ==[[Lipoprotein(a) classification|Classification]]== | ||
== [[Lipoprotein(a) biochemistry|Biochemistry]] == | ==[[Lipoprotein(a) biochemistry|Biochemistry]]== | ||
== [[Lipoprotein(a) physiology|Physiology]] == | ==[[Lipoprotein(a) physiology|Physiology]]== | ||
== Clinical Correlation== | ==Clinical Correlation== | ||
===[[High lipoprotein(a)]]=== | ===[[High lipoprotein(a)]]=== | ||
[[High lipoprotein(a) epidemiology and demographics|Epidemiology and Demographics]] | [[High lipoprotein(a) pathophysiology|Pathophysiology]] | [[High lipoprotein(a) causes|Causes]] | [[High lipoprotein(a) diseases|Diseases]] | [[High lipoprotein(a) prognosis and complications|Prognosis and Complications]] | [[High lipoprotein(a) epidemiology and demographics|Epidemiology and Demographics]] | [[High lipoprotein(a) pathophysiology|Pathophysiology]] | [[High lipoprotein(a) causes|Causes]] | [[High lipoprotein(a) diseases|Diseases]] | [[High lipoprotein(a) prognosis and complications|Prognosis and Complications]] | ||
| Line 20: | Line 20: | ||
[[Low lipoprotein(a) epidemiology and demographics|Epidemiology and Demographics]] | [[Low lipoprotein(a) pathophysiology|Pathophysiology]] | [[Low lipoprotein(a) causes|Causes]] | [[Low lipoprotein(a) diseases|Diseases]] | [[Low lipoprotein(a) prognosis and complications|Prognosis and Complications]] | [[Low lipoprotein(a) epidemiology and demographics|Epidemiology and Demographics]] | [[Low lipoprotein(a) pathophysiology|Pathophysiology]] | [[Low lipoprotein(a) causes|Causes]] | [[Low lipoprotein(a) diseases|Diseases]] | [[Low lipoprotein(a) prognosis and complications|Prognosis and Complications]] | ||
== Treatment == | ==Treatment== | ||
[[Lipoprotein(a) medical therapy|Medical Therapy]] | [[Lipoprotein(a) primary prevention|Primary Prevention]] | [[Lipoprotein(a) secondary prevention|Secondary Prevention]] | [[Lipoprotein(a) landmark trials|Landmark Trials]] | [[Lipoprotein(a) future or investigational therapies|Future or Investigational Therapies]] | [[Lipoprotein(a) medical therapy|Medical Therapy]] | [[Lipoprotein(a) primary prevention|Primary Prevention]] | [[Lipoprotein(a) secondary prevention|Secondary Prevention]] | [[Lipoprotein(a) landmark trials|Landmark Trials]] | [[Lipoprotein(a) future or investigational therapies|Future or Investigational Therapies]] | ||
Revision as of 20:08, 12 September 2013
Template:Lipoprotein(a) Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Biochemistry
Physiology
Clinical Correlation
High lipoprotein(a)
Epidemiology and Demographics | Pathophysiology | Causes | Diseases | Prognosis and Complications
Low lipoprotein(a)
Epidemiology and Demographics | Pathophysiology | Causes | Diseases | Prognosis and Complications
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Landmark Trials | Future or Investigational Therapies